2023 International Congress Archives - Page 179 of 186

Unusual Neuronal Intranuclear Inclusion Disease (NIID) with initial presentation mimicking recurrent Transient Global Amnesia (TGA)

S. Kim, WT. Yoon (Seoul, Republic of Korea)
Unveiling the Link between Stress-Related Disorders and Dysautonomic Symptoms in Parkinson’s Disease: A Cross-Sectional Study

EJ. Acosta-Espinoza, IA. Ortiz-Marroquin, DI. Salinas-Leal, A. Salinas-Blancas, HM. Macias-Cruz, D. Martinez-Ramirez (Monterrey, Mexico)
Unveiling the role of subthalamic nucleus stimulation on freezing of gait in Parkinson disease using wearable sensors

R. Barbosa, P. Pita Lobo, A. Valadas, P. Bastos, S. Alberto, L. Correia Guedes, M. Rosa, R. Matias, M. Coelho (Toulouse, France)
Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Updates on the Outcomes of Botulinum Toxin Injections in Patients with Lower Limb Dystonia

M. Wajid, J. Yu, J. Frey, J. Lopes, A. Dave, L. Kugler, T. Stiep, J. Toledo, A. Ramirez-Zamora, A. Rawls, A. Wagle Shukla, I. Malaty (Gainesville, USA)
Uremic encephalopathy (UE) mimicking acute bulbar stroke with progression from bradykinesia to choreic movements in a diabetic patient undergoing hemodialysis: A case report

B. Qazimllari, A. Kuqo, J. Tana, A. Rroji, A. Rama, A. Verlaku, J. Kruja (Tirana, Albania)
Usability of Parkinson’s KinetiGraph in deep brain stimulation for essential tremor

E. Jiltsova, D. Nyholm (Uppsala, Sweden)
Use and Misuse of the Unified Multiple System Atrophy Rating Scale

A. Ferreirós, S. Castillo-Torres, M. Merello (Buenos Aires, Argentina)
Use of a wearable vibration-based device for the treatment of Parkinson’s disease tremor

C. Stephen, E. Fabara, F. Parisi, B. Pugliese, G. Vergara-Diaz, P. Gochyyev, A. Davanzo, D. Carballo, K. Pina, T. Luu, P. Bonato (Boston, USA)
Use of concomitant medications before and after treatment with levodopa/carbidopa intestinal gel in patients with advanced Parkinson’s disease: summary of phase 3 and real-world studies

J. Boyd, H. Fernandez, W. Poewe, A. Fasano, N. Kovács, K. Chaudhuri, M. Simu, J. Aldred, L. Lopiano, S. Parashos, J. Parra, L. Bergmann, P. Kukreja, M. Shah, O. Ladhani, G. Melzi, C. Yan, A. Antonini (Burlington, USA)